HIFU focal therapy for prostate cancer using intraoperatory contrast enhanced ultrasound.
CONCLUSIONS: Our study shows that the use of Sonovue after HIFU FT was safe. Patients present a significant proportion of failure after HIFU FT but with good functional outcomes and without incidence of severe complications.
PMID: 31579041 [PubMed - in process]
Source: Archivos Espanoles de Urologia - Category: Urology & Nephrology Tags: Arch Esp Urol Source Type: research
More News: Cancer | Cancer & Oncology | High Intensity Focused Ultrasound Therapy | Prostate Cancer | Study | Ultrasound | Urology & Nephrology